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Previous studies showed poor correlation between asthma symptoms and spirometric-
based bronchial provocation tests. Use of impulse oscillometry (IOS) in airways resistance
measurement may be more sensitive. In 20 individuals with stable asthma, we analysed the
relationship between methacholine-induced asthma symptoms scores, IOS and spirometry.
Following a screening visit, methacholine challenge testing was performed twice (visits 1
and 2). Dyspnoea, tightness and wheeze were quantified using visual analogue scores. IOS
and spirometry were conducted at each incremental dose of methacholine. The Pearson
correlation coefficient and linear regression analyses were conducted to explore the
relations. A significant correlation was observed between methacholine-induced dyspnoea
scores and the change in IOS measures of R
5
(r ¼ 0.62, p ¼ 0.004) and X5 (r ¼ 0.51,
p ¼ 0.022), but not with the spirometric changes in FEV
1
(r ¼ 0.37, p ¼ 0.11) or MEF50
(r ¼ 0.32, p ¼ 0.17). In a multiple linear regression model, R5 was the only significant
variable to explain dyspnoea variability (p ¼ 0.003). Results of correlation analyses for
chest tightness were similar to those obtained with dyspnoea. However, the symptom of
wheeze showed correlation with IOS and spirometry. We conclude that airway resistance
measured by IOS during methacholine challenge correlates better with asthma symptoms
than traditional spirometric measures implying a higher sensitivity index.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Spirometry-based non-specific provocation tests are widely
used in measurement of airway hyper-responsiveness,
asthma diagnosis, and in some instances to guide treatment.
However, studies have shown poor correlation between
histamine or methacholine-induced asthma symptoms (e.g.
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IOS correlation with asthma symptoms scores 43dyspnoea) and degree of airway obstruction as measured by
the fall in forced expiratory volume in 1 s (FEV1).
1,2 This is
contributed to by the considerable variation in perception of
symptoms such as dyspnoea between individuals with
asthma. The expression of dyspnoea in asthma is related
to an interplay of complex mechanisms, including change in
lung volume, speed of bronchoconstriction, anxiety level,
duration of asthma and age, attitudes, expectation and
personality traits.3,4 In some situations, the importance of
these factors varies according to the method used to induce
bronchoconstriction. For instance, in histamine and metha-
choline-induced asthma symptoms, the speed of broncho-
constriction and associated lung hyperinflation seem to play
an important part.4,5 Consequently, the lack of good
correlation between methacholine-induced asthma symp-
toms and traditional measurement of bronchoconstriction
(e.g. FEV1) is not surprising.
The forced oscillation technique (FOT) was introduced as
a technique for the assessment of respiratory mechanics by
Dubois et al.6 It employs small-amplitude pressure oscilla-
tions over a wide range of frequencies superimposed on
normal breathing and has the advantage over conventional
lung function techniques that it does not require the
performance of active respiratory manoeuvres. It measures
pulmonary impedance by sending a sound wave produced by
an impulse generator through a mouthpiece during tidal
breathing. The spectral ratio of the amplitude of the
pressure wave signal to the resulting flow signal constitutes
the impedance (Z) of the total respiratory system, through
which the total resistance (Rrs) and reactance (Xrs) of the
total respiratory system is also calculated.7,8 The clinical
potential of the method became apparent because it is
rapid, demands only passive cooperation (no active breath-
ing manoeuvres), is non-invasive, and is particularly suitable
for use in children and in patients with poor coordination.9
The FOT has proved its usefulness in clinical practice and
in instances its superiority to spirometry.10 The sensitivity
of Rrs and Xrs values to experimentally induced changes in
airway obstruction appear to be better at lower frequen-
cies, especially at 5–15Hz, where an earlier rise in
resistance values has been observed to precede the fall in
FEV1.
9,11 Several mechanisms may account for these
differences, including the need for deep inspiration prior
to spirometry which may alter bronchial tone in asthma.12
The influence of the lung volume at which Rrs and Xrs are
measured may also play a role, particularly in the bronchial
challenge setting where a resulting increase in lung volume
due to bronchoconstriction contributes to Rrs and Xrs
values.13
The Jaeger impulse oscillation system (impulse oscillo-
metry (IOS), Erich Jaeger, Hoechberg, Germnay) has been
introduced as user-friendly commercial version of the FOT.
IOS is however, different from the classical FOT because an
impulse (a rectangular wave form) rather than a pseudoran-
dom noise signal (a mixture of several sinusoidal wave
forms) is applied by a loud speaker, and because of
differences in data processing (e.g. use of coherence
function in data acceptance and implementation of simple
models simulating mechanics of the central and peripheral
parts of respiratory system). A limited number of studies
have been published on IOS accuracy compared to FOT,
which generally suggest that the two methods yield similarbut not identical measures of Rrs and Xrs.
22 However, in the
context of methacholine challenge, there is no available
published comparison between IOS and the gold standard
spirometry-based FEV1.
This study examines the hypothesis that symptom scores
in patients with asthma following methacholine challenge
show a different relationship with IOS indices than with
spirometric-based measurements.
Methods
Subjects
Twenty participants with established doctor-diagnosed
asthma of at least 2 years who had demonstrated either
reversible airway disease or bronchial hyper responsiveness
with a PC20p16mg/ml to methacholine, were invited to
participate. Airway reversibility was defined by either an
increase in FEV1X12% after inhaled short-acting b agonist,
salbutamol (400 mg), or a variation of peak flow of X20%
over 50% of time in 2-week period within the previous 12
months. Subjects were aged between 18 and 65 years, had
stable mild to moderate asthma (daily inhaled corticosteroid
dose of p1000 mg beclomethasone dipropionate or equiva-
lent), and had an FEV1X75% predicted. Participants who had
experienced an exacerbation needing oral corticosteroid
treatment within 4 weeks of the screening visit were
excluded. The East Birmingham Local Ethics Committee,
UK, approved the study. All patients gave informed written
consent.
Study design
Participants attended an initial screening review in which
their asthma diagnosis, severity, medication level and
symptoms stability were assessed. Visit 1 was conducted a
week afterwards in which participants undertook baseline
visual analogue score (VAS), IOS measures and flow-volume
loops in that order. Methacholine challenge was then
conducted with measurement of IOS and flow-volume loops
at each doubling dose of methacholine. VAS, IOS and flow-
volume loops were measured immediately after challenge.
To assess reproducibility, the same protocol was repeated
2–3 weeks afterwards at visit 2 having had no respiratory
tract infections, or changed asthma status in the intervening
period, to augment test repeatability.
Impulse oscillometry (IOS)
The IOS MasterScreen device (E. Jaeger GmbH, Wurzburg,
Germany) consists of a loudspeaker as a pulse generator to
send the pressure impulses to the respiratory system.14
During tidal breathing, through a plastic mouthpiece, the
impulse generator produces brief pressure pulses at inter-
vals of 0.2 s. The superimposed pressure oscillations during
normal spontaneous breathing are composed of several
frequencies allowing assessment of R and X at several
frequencies simultaneously. A fast Fourier analyser is
employed within the system to determine Rrs and Xrs at
these frequencies. The impedance (Zrs) representing a
ARTICLE IN PRESS
A.H. Mansur et al.44complex airway resistance, which includes two components,
the real resistance (Rrs) and the imaginary reactance (Xrs),
has also been determined. The frequency range of the signal
was from 0 to 100Hz, and we recorded R5–20 and X5. Rrs at 5
and 20Hz represent the low (total resistance) and high
(central resistance) frequency range, respectively. In this
asthmatic group, the low frequency R5 was used as primary
parameter on the basis of previous studies reporting its
reliability in assessing bronchial responsiveness.15
During IOS measurements subjects sat upright with the
head in neutral position, and a nose clip in place, while
supporting their cheeks with their hands.15 Monitoring took
place for 30 s over a few respiratory cycles of quiet
breathing and when the subjects got used to the forcing
signal, baseline impedance measurements were recorded
over 30 s before challenge testing. The results were
averaged over the entire 30 s during which 150 impulses
were applied. IOS measurements were systematically
applied prior to any forced respiratory manoeuvre and
repeated in the same order after each methacholine
challenge step.Forced flow volume measurements
Before bronchial challenge testing maximal flow volume
measurements were performed using a Jaeger-Masterlab
(E. Jaeger GmbH, Wurzburg, Germany). The following
parameters were measured: FEV1, and the maximal ex-
piratory flows at 25%, 50% and 75% of vital capacity (MEF25,
MEF50, and MEF75), using the European Community for Coal
and Steel normal values.16 The largest FEV1 value from three
acceptable manoeuvres was used as the baseline FEV1.
17Visual analogue score (VAS)
A VAS was used to assess dyspnoea, tightness and wheeze at
the start and end of the methacholine challenge.18 Subjects
were instructed to score for each symptom without being
able to see the score they had recorded at any previous time
point.Methacholine challenge
Subjects abstained from using b2-agonist inhalers (6–12 h),
oral b2-agonist (24 h), cromolyns (24 h), xanthines (24 h),
and anti-cholinergics (8–24 h) prior to challenge. Subjects
were administered a methacholine aerosol inhalation test
according to a 5 breath dosimeter protocol.19 After baseline
measurements of IOS and spirometry in that order, subjects
inhaled one bolus of 0.9% saline followed by increasing
doses of methacholine (saline, 0.0625, 0.25, 1, 4, 16, and
32mg/ml) at no greater than 3min intervals. IOS measure-
ments were repeated at 60 s and spirometry at 90 s after
each inhalation dose. The test was stopped: (a) following a
decrease of 420% in the FEV1; (b) when the maximal
provocation concentration of 32mg/ml was reached; and
(c) if the subject felt symptomatically unwell.Statistical analysis
Statistical analysis used SPSS version 10.0 (Chicago, USA).
Distribution parameters were summarised by minimum and
maximum values range, mean and standard deviation (SD)
unless indicated otherwise. To confirm a significant effect of
provocation testing on VAS, IOS, and spirometry parameters,
differences between post- and pre-challenge values were
calculated for visits 1 and 2. The mean of differences
(Ddyspnoea, Dtightness, Dwheeze, DR5, DX5, DFEV1, and
DMEF50), were tested by being different from zero by the
paired t-test and the Wilcoxon matched-pairs test. Repeat-
ability of the values of Ddyspnoea, Dtightness, Dwheeze,
DR5, DX5, DFEV1, and DMEF50 between visits 1 and 2, was
analysed by Bland and Altman plots using MedCalcs version
9.0.1.0 (www.medcalc.be).35
To study the relationships between VAS, IOS and spirometry
parameters, Pearson’s correlation coefficients were calcu-
lated. In this analysis, the change in FEV1 and MEF50 values
from baseline to end of methacholine challenge were
expressed as a percentage ‘‘%D ¼ baseline—post-challenge/
baseline 100’’, while for R5 and X5 values the %D is
calculated as ‘‘post-challenge—baseline/baseline  100’’.
For dyspnoea, tightness and wheeze the D value was used as
it represents a pre- and post-challenge change across a
100mm visual scale.
Stepwise forward linear regression analysis between the
dependent variable ‘‘Ddyspnoea’’ and co-variables DR5,
DX5, DFEV1, and DMEF50 was also conducted to explore the
co-variables that fit the model best. Statistical significance
was assumed if p-values were o0.05.
Results
Subjects characteristics
Twenty participants met the inclusion criteria and under-
went methacholine challenges on two occasions. Their
clinical details are summarised in Table 1. The mean results
of visits 1 and 2 bronchial challenges are shown in Table 2.
Bland Altman plots display the repeatability of these results
(Figure 1). Allowing for outliers the results of VAS, IOS, and
spirometry revealed repeatable results to within 2 SDs on
both sides of the arithmetic mean (Figure 2).
Overall there were statistically significant increases in
values of dyspnoea, tightness, wheeze, R5, X5, and
decreases in FEV1 and MEF50 (po0.001) following challenge.
In visit 1, all but five individuals achieved FEV1 PC20 of
o32mg/ml. In four subjects, the challenge was discon-
tinued prematurely due to development of significant
asthma symptoms. Their provocation results were PC18.7
at 4mg/ml, PC16.4 at 0.25mg/ml, PC18.7 at 4mg/ml and
PC17.5 at 4mg/ml. However, three of them achieved PC20
o16mg/ml in visit 2, but the fourth subject’s challenge was
discontinued prematurely again at PC13.1 (16mg/ml) due to
worsening symptoms. The fifth individual’s PC20 was
432mg/ml with FEV1 drop of 14.1% and 18.6% in visits 1
and 2, respectively. She has an established diagnosis of
asthma since childhood, which is treated with seretide
(fluticasone 100mcg/salmeterol 50mcg) 2 doses twice a day
and salbutamol as required.
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IOS correlation with asthma symptoms scores 45Twelve subjects were receiving inhaled corticosteroids,
ICS (mean dose ¼ 809 mg beclomethasone equivalent), while
the remaining 8 were not receiving ICS. We observed no
difference in symptom scores, spirometry or IOS measure-
ment between steroid naı¨ve and steroid treated groups
(data not shown).Correlation between symptoms and lung function
indices
Results are shown in Table 3. Dyspnoea scores correlated
closely with symptoms of chest tightness (r ¼ 0.94) and
wheeze (r ¼ 0.80), and with IOS measurements (for R5,
r ¼ 0.63, X5, r ¼ 0.60 and Z5 r ¼ 0.68; p values for all
o0.01), but not with FEV1 (r ¼ 0.37, p40.05) or MEF50
(r ¼ 0.35, p40.05). However, FEV1 and MEF50 showed weak
but significant correlations with wheeze. Changes in the IOSTable 1 Demographic details of the subjects.
Patient characteristics Range (mean–SD)
Age in years 18–62 (34.5711.2)
Height (cm) 147–183 (16278)
Weight (kg) 51–98.4 (66.76712.7)
Sex (m/f) 3/17
Tobacco pack years 0.0–1.0 (0.11)
FEV1 (% pred) 78.5–135.7 (99.7717.2)
MEF50 (% pred) 39.7–131.7 (70.6723.3)
FEV1/FVC 60.8–93.4 (80.479.4)
ICS (mg) 0–1000 (4857412)
Values are presented as minimum–maximum range (mean7SD).
Relative values of spirometry parameters are given as
percentage of the predicted value (% pred).
Abbreviations: FEV1: forced expiratory volume in 1 s; MEF50:
maximal expiratory flow at 50% of vital capacity; ICS: inhaled
corticosteroids.
Concurrent treatment dose of beclomethasone dipropio-
nate or equivalent.
Table 2 Methacholine challenge results for visits 1 and 2.
Visit 1
Pre Post D % D
Dyspnoea 3.275.6 35.5726.3 32.5726.7
Tightness 6.778.4 41.0724.8 34.4725.5
Wheeze 4.478.8 31.4722.8 27.0725.4
R5 (kPa/l/s) 0.4870.17 0.7570.2 0.2770.17 61.7737.4
X5 (kPa/l/s) 0.1870.1 0.3470.3 0.1670.24 84.8765.6
FEV1 (l) 2.970.5 2.270.4 0.6870.27 23.778.0
MEF50 (l/s) 3.071.0 2.070.7 1.170.57 38.8722.7
Results are shown as means7standard deviation for pre- and post-me
(D) and its percentage (%D). The dyspnoea, tightness and wheeze va
and ‘‘post’’-methacholine challenge measurements, therefore no perc
visits 1 and 2 for measured parameters is also given.36 This represents
subject standard deviation was calculated from the square root of th
visits 1 and 2 results. Abbreviations: R5: resistance at oscillation fr
l ¼ litre; l/s: litres per second; kPa/l/s: kilo-Pascal per litre per secmeasurement R5 preceded change in spirometry (FEV1)
during the methacholine challenge (data not shown).
We observed no significant correlation between R5 and
spirometry measurements, however, X5 showed a weak but
statistically significant correlation with FEV1 (r ¼ 0.45,
po0.05) and MEF50 (r ¼ 0.47, po0.05).
Linear regression analysis
Linear regression of post-challenge change in dyspnoea
scores (D dyspnoea) on % post-challenge increase in
R5 (%DR5) showed a significantly positive relationship
(p ¼ 0.004, R2 ¼ 0.38). Conversely, the relationship be-
tween D dyspnoea and % post-challenge decrease in FEV1
(%DFEV1) using linear regression was not significant
(R2 ¼ 0.14, p ¼ 0.11) (Figure 1).
In a forward stepwise multiple linear regression model,
co-variables, which would explain the dependent variable
‘‘dyspnoea’’ were explored. R5 showed the most significant
slope (p ¼ 0.003), while the addition of the other co-
variables was not statistically significant (Table 4).
Discussion
In patients with well-established and stable asthma, we
investigated the relationship between methacholine-in-
duced asthma symptoms scores, IOS measured resistance
(Rrs) and reactance (Xrs), and the spirometry derived ‘‘gold
standard’’ FEV1 and MEF50. We demonstrated a significant
correlation between dyspnoea scores and IOS but not with
spirometry. To our knowledge, this is the first study that has
examined the correlation between IOS indices and asthma
symptoms as a primary outcome following methacholine
challenge.
Both R5 and X5 correlated significantly with methacholine-
induced dyspnoea, tightness and wheeze, while FEV1 and
MEF50 showed no significant correlation except for a
borderline correlation with wheeze. Post-methacholine-
induced dyspnoea showed a closer relationship with tight-
ness than wheeze. Indeed, the correlation pattern ofVisit 2 Repeat-
ability
Pre Post D %D
7.5718 36.4728.5 35.2728.5 27.8
5.477.3 44.7725.8 39.3725.5 31.7
3.677.6 30.1725.1 30.5726.7 26.1
0.4870.16 0.7770.2 0.2970.17 64.5738.4 54.5%
0.1570.1 0.3670.23 0.2170.15 1507112 182.3%
2.970.6 2.170.5 0.7670.4 22.779.8 16.9%
3.071.1 1.970.8 1.1470.86 37.3717.9 33.0%
thacholine challenge values and the difference between the two
lues represent actual change on a 100mm scale between ‘‘pre’’-
entage was calculated. Measurement of error ‘‘repeatability’’ of
within subject standard deviation multiplied by 2.77. The within
e variance which represents half of the square of differences of
equency of 5Hz; X5: reactance at oscillation frequency of 5Hz;
ond.
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Figure 1 Repeatability of the two visits results using Bland–Altman plots. Comparison is made between post-challenge change in
(i) dyspnoea scores, (ii) %R5, and (iii) %FEV1. Similar results were obtained for tightness, wheeze, X5 and MEF50 scores (data not
shown).
A.H. Mansur et al.46dyspnoea and tightness symptoms with both IOS and
spirometry was similar and somewhat different from wheeze
(Table 3). A possible explanation for such findings is a
differing underlying pathophysiology. Dyspnoea and possibly
chest tightness originate in complex and not yet fully
understood mechanisms that include increased resistive
work of breathing through activation of respiratory muscle,
hyperinflation, and non-mechanical stimuli.5,34 Wheeze on
the other hand might be a true representation of the actual
airway calibre and hence its significant correlation with
spirometry.20
Our findings of close correlation between methacholine-
induced dyspnoea and R
5
but not FEV1, is consistent with
earlier reports of increased sensitivity of the FOT over
spirometry in subjects with either reactive airways disease
or those exposed occupationally to toxic fumes or other
inhalants.11 Schmekel and Smith used inhalation of cold air
as a bronchial challenge test in both asthmatics and healthy
controls. Their results indicated that FOT was more able to
discriminate between the two groups than spirometry with
superior specificity and sensitivity (89% and 88% for R5 and
88% and 73% for FEV1, respectively).
21 IOS is somewhat
different from the classical FOT. Hellinckx et al.22 comparedthe two techniques and concluded that the two systems
were similar but not identical in measurement of respiratory
system resistance and reactance. More recent IOS-based
studies continued to report similar findings of increased
sensitivity of the oscillation technology. Kohlhaufl et al.23
examined healthy non-smokers versus asymptomatic smo-
kers, and demonstrated a three times higher post-metha-
choline challenge reactance values as compared to FEV1 in
the asymptomatic smokers group, which were attributed to
possible underlying subclinical bronchiolitis. Skloot et al.24
assessed ironworkers at the World Trade Centre disaster
site, and reported that spirometry significantly under-
estimated the prevalence of lung function abnormalities in
symptomatic subjects as compared with IOS.
The role of methacholine challenge testing in asthma
diagnosis has been previously reviewed, and is largely seen
to have high negative predictive value of more than 90%
when the pre-test asthma probability is 30–70%.19 Further-
more, most authors conclude a negative methacholine
challenge will virtually rule out asthma if the subject was
symptomatic in the 2 weeks prior to the test. However, it is
clear that a significant proportion of asthmatics do not
consistently reach this diagnostic gold standard (PC20–FEV1)
ARTICLE IN PRESS
IOS correlation with asthma symptoms scores 47despite development of asthma symptoms during the
challenge (e.g. chest tightness or dyspnoea).2 Several
studies have reported significant correlations between the0 20 40 60 80
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Figure 2 Linear regression analysis of post-methacholine
challenge changes in dyspnoea scores (Ddyspnoea), on % change
in R5 (%DR5) (Fig. 1a), and % change in FEV1 (%DFEV1) (Fig. 1b).
A significant relationship is observed between D dyspnoea and
%DR5, but not with %DFEV1. (For abbreviations, please refer to
Tables 2 and 3 legends.)
Table 3 Changes in symptom scores following challenge.
DDyspnoea DTightness DWheez
DDyspnoea 1.0 0.95** 0.80**
DTightness 1.0 0.86**
DWheeze 1.0
%DR5
%DX5
%DFEV1
%DMEF50
The dyspnoea, wheeze and tightness values represent mean change
measured on 100mm scale. The R5, X5, FEV1 and MEF50 variables are
methacholine challenge. The D and %D values correspond to the mean
statistical significance are marked in bold as (*po0.05, **po0.01,
parametric Spearman’s coefficient yielded very similar results.changes in FOT measured Rrs and FEV1 following induced
bronchoconstriction25–27 while others including this study
showed no significant correlation.22 Broeders et al. com-
pared the FOT measured PC40–R6 with the PC20–FEV1 in
stable asthmatics,10 and showed that PC40–R6 was achieved
at a significantly lower methacholine concentration than
PC20–FEV1 and in shorter time span. Such discrepancy
between FOT and spirometry is probably a reflection of
differences in the conduct of their measurements. Maximal
inspirations and forced expirations in spirometry require full
patient cooperation, and repeated manoeuvres may fatigue
the respiratory muscle. Previous studies also showed that
repeated deep inspiration can induce bronchodilation
particularly in asymptomatic asthmatics, which could
influence the outcome of a bronchial provocation test.28–32
IOS has the advantage of only requiring quiet breathing
without the need for an initial deep inspiration. However, in
our study, the deep inspiration required for spirometry may
influence subsequent IOS as well as spirometric measure-
ments during the challenge. Conducting a study that
compares IOS-based methacholine challenge alone versus
IOS and spirometry together may be useful in addressing this
issue. Differences between FEV1 and Rrs may also reflect
differences in the various aspects of the pathophysiology ofe %DR5 %DX5 %DFEV1 %DMEF50
0.63** 0.60** 0.37 0.35
0.59** 0.51* 0.42 0.46
0.48* 0.62** 0.49* 0.46*
1.0 0.58** 0.28 0.37
1.0 0.45* 0.47*
1.0 0.75**
1.0
(D) from baseline following methacholine challenge, which is
represented as the mean % change (%D) from baseline following
of the combined values for visits 1 and 2. Correlations that reach
two tailed). In addition to Pearson’s coefficient analysis, non-
Table 4 Results of stepwise forward linear regression of
Ddyspnoea on %DR5, %DX5, %DFEV1 and %DMEF50 (repre-
senting mean values of the percentage of difference
between pre- and post-methacholine challenge for visits
1 and 2 combined).
Model Regression
coefficient
Standard
error
T p
Included variables
Constant 3.5 1.0 0.35 0.73
%DR5 0.49 1.4 3.5 0.003
Excluded variables
%DX5 0.36 1.7 NS
%DFEV1 0.21 1.13 NS
%DMEF50 0.13 0.65 NS
The sum of squares for %DR5 is 4955.64/12320.2, R
2 ¼ 40%.
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A.H. Mansur et al.48airflow obstruction (e.g. small airway inflammation) that
were not detected by FEV1, but were correctly detected by
Rrs. It may be argued therefore that Rrs could have a higher
sensitivity and lower false negative rate than FEV1 in asthma
diagnosis in methacholine challenge setting. Conversely, the
replacement of FEV1 with Rrs in methacholine challenge
tests may exaggerate the overlap of positive bronchial
hyperresponsiveness between asthmatics and individuals
who have rhinitis and no lung disease for example, thus
reducing the test specificity and the positive predictive
value for asthma. To be integrated in clinical use, IOS-based
bronchial provocation testing will require further character-
isation of its sensitivity and specificity in relation to FEV1 in
larger normal and asthmatic populations.
Studies on the reproducibility of oscillometry-based
techniques indicated 5–15% intra-individual variability
which is comparable to the variability of resistance values
of other methods such as body plethysmography.13 In this
study, to confirm validity and repeatability of our results,
subjects underwent two bronchial challenges 2–3 weeks
apart. These showed close result repeatability between the
two visits (Table 2, Figure 1). The IOS parameters (R5 and X5)
showed similar correlation pattern in relation to asthma
symptoms. However, in contrast to R5, X5 demonstrated
significant correlation with FEV1 and MEF50. This finding is
consistent with previous studies that demonstrated more
negative (decreased) reactance ‘‘Xrs’’ as airways obstruction
increases, which appeared to correlate more strongly with
FEV1 and plethysmographic airway resistance (Raw) than did
Rrs.
11 The Xrs of the respiratory system represents the
spectral relationship between the pressure component out
of phase with flow and the flow. It is thought to reflect the
inertive and elastic properties of the lungs rather than a
measure of airway obstruction, which is intriguing consider-
ing its reported correlation with other measures of airway
resistance. Johnson et al. recently reported that Xrs could
predict transpulmonary resistance (measured by oesopha-
geal manometry) more accurately than can the Rrs.
33
Increased susceptibility of Rrs, as opposed to Xrs, to upper
airway wall shunting was put forward as a possible
explanation. However, in our multiple regression model
(Table 3), R5 was the only significant variable that explained
dyspnoea, which further emphasised its role as a candidate
measurement in bronchial provocation tests.
It is not yet clear which cut-off value for R5 would
correspond to bronchial hyperresponsiveness. Previous
studies suggested that threshold values up to a 47% increase
in R5–10 are associated with a higher number of positive
responders than is the case of PC20–FEV1, while other studies
estimated this threshold value lies between a 65% and 90%
increase in R5–10.
15 Our study design does not allow the
estimation of such a threshold, although in this sample of
stable asthmatics we observed a mean post challenge
change in R5 of 61.7% (SD ¼ 37.4) in visit 1 and 64.5%
(SD ¼ 38.4) in visit 2. Rrs at higher frequency (R20) have also
been analysed in this study. We observed no significant
correlation between asthma symptoms and R20 (the Pearson
correlation of Ddyspnoea to %DR20 ¼ 0.064, p ¼ 0.79). R20
represents the upper and central resistance measure and its
relative value to R5 rather than its absolute value which has
been shown to be useful in determining clinical entities such
as upper airway dysfunction (R20 larger than R5).In conclusion, we have shown a significant correlation
between IOS-based measurements of respiratory resistance
and methacholine-induced asthma symptoms. In contrast,
the correlation of such symptoms with spirometric-based
measurements was either non-significant or weak. These
data therefore support the notion of IOS superiority to
spirometry in assessment of bronchial responsiveness. The
ease of IOS data acquisition and its superior sensitivity to
spirometry in methacholine challenge would argue for a
further study in a large population to establish the
sensitivity and specificity of IOS-based methacholine chal-
lenges in asthma diagnosis and monitoring. This would also
be important in the understanding of symptoms such as
chest tightness of which patients frequently complain but
are often dismissed as they bear little consistent relation-
ship to indices of conventional lung function assessment.Conflict of interest
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